Phibro Animal Health reported $415.62M in Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Align Technology ALGN:US $ 0M 0M
Ani Pharmaceuticals ANIP:US $ 287.16M 0.21M
Aurora Cannabis Inc ACB:CN 388.14M 26.31M
Bristol Myers Squibb BMY:US $ 44972M 419M
Canopy Growth Corp WEED:CN C$ 1.5B 152.36M
Corcept Therapeutics CORT:US $ 0M 0M
Depomed DEPO:US $ 73.52M 0.03M
Eli Lilly And LLY:US $ 16508.8M 375.9M
Endo International Ordinary Shares ENDP:US $ 8090.62M 183.92M
Henry Schein HSIC:US $ 866M 6.52M
Idexx Laboratories IDXX:US $ 1173.38M 249.68M
JAZZ PHA JAZZ:US $ 6023.87M 32.75M
Knight Therapeutics Inc GUD:CN C$ 46.79M 5.83M
Lannett LCI:US $ 610.08M 6.6M
Merk MRK:US $ 31794M 1308M
Nektar Therapeutics NKTR:US $ 0M 0M
Pacira Pharmaceuticals PCRX:US $ 923.42M 125.81M
Patterson Companies PDCO:US $ 623.35M 8.49M
Phibro Animal Health PAHC:US $ 415.62M 15.18M
Prestige Brands PBH:US $ 1483.91M 53.86M
Supernus Pharmaceuticals SUPN:US $ 400.38M 21.13M
Teva Pharmaceutical Industries TEVA:US $ 22917M 126M
Zoetis ZTS:US $ 6578M 14M